Genetic Epidemiology and Biostatistics

Platform Leader
Dr. Lyle Palmer
OICR

The Genetic Epidemiology and Biostatistics Platform will conduct research centred on the benefits of genomics for human health and on the interface between basic science and clinical impact. It will develop the tools to analyze data for new knowledge about the causes and progression of cancer and related conditions. It will also assist in the translation of this new knowledge into prevention and health promotion strategies.